日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metabolism-related ALDH1B1 acts as potential predictor and therapeutic target for primary gastrointestinal diffuse large B-cell lymphoma.

代谢相关的ALDH1B1可作为原发性胃肠道弥漫性大B细胞淋巴瘤的潜在预测因子和治疗靶点

Qiao Qiqi, Liu Bingyu, Shang Juanjuan, Sun Wenyue, Zhou Xiaoli, Fang Xiaosheng, Hu Shunfeng, Wang Xin

Highly Transparent Anti-Smudge Coatings for Self-Cleaning, Controllable Liquid Transport, and Corrosion Resistance

用于自清洁、可控液体输送和耐腐蚀的高透明防污涂层

Xu, Hua; Chen, Chao; Hu, Shunfeng; Chen, Yiqi; Duan, Dengle; Liang, Guowei; Zhong, Ximing

Proteome-wide mendelian randomization identifies FCRL3 and LY9 as potential therapeutic targets for lymphoma

全蛋白质组孟德尔随机化分析鉴定出 FCRL3 和 LY9 是淋巴瘤的潜在治疗靶点。

Guo, Qianqian; Shang, Juanjuan; Liu, Bingyu; Ding, Mei; Han, Yang; Luo, Yingshu; Wang, Xin; Hu, Shunfeng

Recent advances in oncolytic virus combined immunotherapy in tumor treatment

溶瘤病毒联合免疫疗法在肿瘤治疗中的最新进展

Zhou, Xiaoli; Hu, Shunfeng; Wang, Xin

Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies

免疫检查点抑制剂在血液系统恶性肿瘤中的进展和临床应用

Sun, Wenyue; Hu, Shunfeng; Wang, Xin

The regulatory roles and clinical significance of glycolysis in tumor

糖酵解在肿瘤中的调控作用及其临床意义

Qiao, Qiqi; Hu, Shunfeng; Wang, Xin

Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies

靶向自然杀伤细胞:从基础生物学到血液系统恶性肿瘤的临床应用

Shang, Juanjuan; Hu, Shunfeng; Wang, Xin

N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9

N-乙酰转移酶10通过N4-乙酰胞苷修饰SLC30A9来调节AMPK/mTOR信号通路,从而促进弥漫性大B细胞淋巴瘤的肿瘤发生。

Ding, Mengfei; Yu, Zhuoya; Lu, Tiange; Hu, Shunfeng; Zhou, Xiangxiang; Wang, Xin

Applications of single-cell technologies in drug discovery for tumor treatment

单细胞技术在肿瘤治疗药物研发中的应用

Liu, Bingyu; Hu, Shunfeng; Wang, Xin

Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma

营养因素对结外NK/T细胞淋巴瘤预后评分系统的推导与验证

Lu, Tiange; Shi, Xue; Ge, Xueling; Li, Ying; Cai, Yiqing; Chen, Xiaomin; Hu, Shunfeng; Ding, Mei; Fang, Xiaosheng; Liu, Fang; Zhou, Xiangxiang; Wang, Xin